A Clinical Trial Now Testing a Novel, Engineered Enzyme for Patients with Classical Homocystinuria

In a recent article appearing in BioPortfolio, Orphan Technologies announced a Phase 1/2 clinical trial involving the first Classical Homocystinuria (HCU) patients to be treated with OT-58. Twelve patients were enrolled as…

Continue Reading A Clinical Trial Now Testing a Novel, Engineered Enzyme for Patients with Classical Homocystinuria
Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?
stevepb / Pixabay

Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?

According to a story from Andre Eger, the drug developer Gilead recently had the misfortune to announce that its clinical trial testing an experimental drug for late stage nonalcoholic steatohepatitis…

Continue Reading Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?

Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

According to a study published in the Orphanet Journal of Rare Diseases, a study that was intended to identify a new approach to monitoring the progression of x-linked adrenoleukodystrophy in women…

Continue Reading Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

Sexual Abuse in Medical Research: How Can Justice be Served?

Content Warning: The following article discusses sexual abuse. According to a story from Buzzfeed News, many former patients of an esteemed medical researcher named Reginald Archibald, who was affiliated with…

Continue Reading Sexual Abuse in Medical Research: How Can Justice be Served?

Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

According to a story from IT Business Net, the medical company KIYATEC, Inc., has recently announced that that the Knight Cancer Institute at Oregon Health & Science University has joined…

Continue Reading Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

The Oshi App: A New Way to Track Your Inflammatory Bowel Disease Symptoms

Inflammatory Bowel Disease Inflammatory bowel disease (IBD) is an autoimmune condition which causes inflammation throughout the digestive tract. There are two main forms of the condition- Crohn's disease and the…

Continue Reading The Oshi App: A New Way to Track Your Inflammatory Bowel Disease Symptoms

Chronic Fatigue Syndrome: Debates on Exercise and the Importance of the Patient Voice

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) are interchangeable titles used to describe the same illness. Sometimes this illness is simply referred to as ME/CFS.…

Continue Reading Chronic Fatigue Syndrome: Debates on Exercise and the Importance of the Patient Voice

New Treatment for GEP-NETs Approved in Canada

According to a story from pm360online.com, the Novartis company Advanced Accelerator Applications S.A. recently announced that Health Canada has issued approval for Lutathera™ as a treatment for gasteroenteropancreatic neuroendocrine tumors…

Continue Reading New Treatment for GEP-NETs Approved in Canada

Can Amyotrophic Lateral Sclerosis Patients Speak Again With New Technology?

The Importance of Speech The ability to speak gives individuals not only the opportunity to communicate with one another, it provides an outlet for expression, creativity, and connectedness. Unfortunately, that…

Continue Reading Can Amyotrophic Lateral Sclerosis Patients Speak Again With New Technology?
4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome
birgl / Pixabay

4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome

According to a story from abc13.com, Makenna Brown, a four-year-old girl from Texas, has been plagued by relentless itching thanks to her Alagille syndrome, a rare genetic disorder. Her distressed…

Continue Reading 4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome
New Funding Program to Support Newborn Screening for Duchenne Muscular Dystrophy
Source: Pixabay

New Funding Program to Support Newborn Screening for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a rare, progressive, and fatal condition. It primarily affects males (1 out of every 3,600 to 6,000 male births). It's caused by…

Continue Reading New Funding Program to Support Newborn Screening for Duchenne Muscular Dystrophy

Bernie Sanders Fights Back Against 375,000 Price Tag for Lambert-Eaton Myasthenic Syndrome Treatment

Lambert-Eaton Myasthenic Syndrome Lambert-Eaton Myasthenic syndrome (LEMs) is a rare autoimmune disease. The body's immune system targets nerve cells meaning patients experience muscle weakness. Other symptoms of LEMs include difficulty walking…

Continue Reading Bernie Sanders Fights Back Against 375,000 Price Tag for Lambert-Eaton Myasthenic Syndrome Treatment
The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
johnhain / Pixabay

The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma

According to a story from pm360online.com, The National Brain Tumor Society (NBTS) recently awarded $750,000 to the Global Coalition for Adaptive Research. This cash is slated to go towards the…

Continue Reading The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma